Preferred Label : incobotulinumtoxinA;
MeSH note : contains the 150 kD neurotoxin without complexing proteins;
MeSH synonym : BoNT-A;
MeSH hyponym : NT-201; NT201;
Registry Number MeSH : EC 3.4.24.69;
Is substance : O;
UNII : EC 3.4.24.69;
Origin ID : C545476;
UMLS CUI : C2930113;
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
http://www.has-sante.fr/portail/jcms/c_2676759/fr/xeomin
2016
false
France
French
evaluation of the transparency committee
botulinum toxin
neuromuscular agents
blepharospasm
adult
torticollis
muscle spasticity
botulinum toxins, type A
injections, intramuscular
treatment outcome
upper extremity
clinical trials as topic
incobotulinumtoxinA
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/xeomin_23052012_avis_ct11992.pdf
http://www.has-sante.fr/portail/jcms/c_1256025/xeomin
2012
France
French
evaluation of the transparency committee
incobotulinumtoxinA
incobotulinumtoxinA
incobotulinumtoxinA
botulinum toxins, type A
botulinum toxins, type A
neuromuscular agents
neuromuscular agents
injections, intramuscular
treatment outcome
botulinum toxin
adult
blepharospasm
torticollis
muscle spasticity
stroke
randomized controlled trials as topic
comparative study
---
http://www.has-sante.fr/portail/jcms/c_1294080/xeomin-synthese-23052012
http://www.has-sante.fr/portail/jcms/c_1257464/xeomin-23052012-avis-ct11992
http://www.has-sante.fr/portail/jcms/c_1294174/xeomin-50-u-toxine-botulique-de-type-a
2012
France
French
guidelines for drug use
evaluation of the transparency committee
botulinum toxin
neuromuscular agents
blepharospasm
adult
torticollis
muscle spasticity
botulinum toxins, type A
injections, intramuscular
treatment outcome
upper extremity
clinical trials as topic
incobotulinumtoxinA
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-04/xeomin_-_ct_-_9626_2011-04-15_15-31-36_292.pdf
http://www.has-sante.fr/portail/jcms/c_1058980/xeomin-neurotoxine-de-clostridium-botulinum-de-type-a-myorelaxant
2011
France
French
guidelines for drug use
evaluation of the transparency committee
botulinum toxins, type A
neuromuscular agents
muscle spasticity
upper extremity
adult
stroke
botulinum toxin
injections, intramuscular
treatment outcome
incobotulinumtoxinA
---
http://www.has-sante.fr/portail/jcms/c_657773/xeomin
2008
France
French
neuromuscular agents
botulinum toxins, type A
adult
insurance, health, reimbursement
blepharospasm
torticollis
injections, intramuscular
botulinum toxin
incobotulinumtoxinA
evaluation of the transparency committee
---